Acta_Neuropathologica_Communications_Logo_Draft_02

First Page		Document Content
Biotechnology Induced pluripotent stem cell Cell biology Cellular differentiation Dura mater Stemgent Dermal fibroblast Fibroblast Basic fibroblast growth factor Biology Stem cells Developmental biology		Acta_Neuropathologica_Communications_Logo_Draft_02 Add to Reading List Source URL: www.ncbi.nlm.nih.gov Download Document from Source Website File Size: 2,62 MB Share Document on Facebook

	Stemgent, a ReproCELL Group Company Announces a New High Performance Self-replicative RNA Reprogramming Kit June 30, 2015 YOKOHAMA, Japan--(BUSINESS WIRE)--We are pleased to announce that Stemgent Inc. (Cambridge, MA), a DocID: 1l5BW - View Document
	Stemgent, a ReproCELL Group Company and Transposagen Biopharmaceuticals enter into a service partnership agreement providing genetically engineered stem cells February 16, 2015 —Stemgent, Inc., A ReproCELL Group Compan DocID: 1fia6 - View Document
	Stemgent mRNA User Manual DocID: 1cYDO - View Document
	CORPORATE FACT SHEET \| JanuaryFrom experience to insight. Company Overview Type: DocID: 1bYm9 - View Document
	“Reprogramming can be a Transforming experience” Jose M. Polo Department of Anatomy and Developmental Biology Australian Regenerative Medicine Institute Monash University DocID: 14ogx - View Document